Can normal HbA1c and fasting insulin miss post-meal glucose spikes when fasting glucose is above optimal?

Above-optimal fasting glucose can coexist with otherwise reassuring laboratory results, because fasting, average, and post-challenge glycemia capture different aspects of glucose regulation.

Clinical evidence

• Normal HbA1c does not exclude post-prandial dysglycemia. HbA1c reflects integrated average glycemic exposure, so transient meal-related elevations may not raise it beyond a diagnostic cutoff. ADA criteria recognize fasting plasma glucose, HbA1c, and 2-hour glucose during a 75-g OGTT as distinct tests: prediabetes may be identified by fasting glucose 100–125 mg/dL or 2-hour glucose 140–199 mg/dL, even with an HbA1c below the prediabetes range.
• Thus, in someone with fasting glucose above optimal, normal HbA1c should not be taken as evidence that post-meal glucose is necessarily normal. OGTT directly tests the relevant post-load physiology. CGM can reveal free-living excursions, but its diagnostic thresholds in people without diabetes are not yet standardized.

Insulin and mechanisms

• A normal fasting insulin is not a diagnostic test for prediabetes or diabetes and does not directly assess post-meal glucose handling. It is therefore plausible that it can appear normal despite intermittent excursions.
• The biologic rationale is early beta-cell dysfunction, particularly reduced first-phase insulin secretion. In isolated impaired fasting glucose, fasting insulin may resemble that in normal glucose tolerance despite substantially impaired early insulin release. Delayed or inadequate early insulin response can permit higher post-prandial glucose despite a normal fasting insulin result.

Clinical implications

• Discordant results merit confirmation with repeat testing or another accepted glucose-based test, accounting for factors that can affect HbA1c or glucose interpretation.
• Bottom line: The claim is well supported for HbA1c and mechanistically credible for fasting insulin. When fasting glucose is above optimal, OGTT is the established method to determine whether clinically relevant post-challenge dysglycemia is present; fasting insulin and HbA1c alone cannot reliably exclude it.